Abstract
Injection has long since been a barrier to insulin use. However, previous attempts to produce an inhaled insulin have met with difficulty. Technosphere insulin is a new system for delivery of inhaled insulin and is currently under review by the FDA. In this Drug profile, the authors discuss the technology and review the clinical data relating to its efficacy and adverse effects. Copyright © 2012 John Wiley & Sons, Ltd.
Cite
CITATION STYLE
APA
Sarala, N., Bengalorkar, G., & Bhuvana, K. (2012). Technosphere: new drug delivery system for inhaled insulin. Future Prescriber, 13(1), 14–16. https://doi.org/10.1002/fps.90
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free